ABSTRACT
INTRODUCTION
Insulin resistance is a common pathological state wherein target tissues produce a less than normal response to circulating insulin. This plays a central role in the development Type 2 diabetes and is commonly associated with conditions such as obesity, polycystic ovary syndrome, sepsis, cachexia, cancer, hypertension and cardiovascular disease. Understanding the molecular mechanisms involved in the regulation of both normal and deregulated insulin signalling may therefore be key to identifying novel diagnostic and therapeutic strategies.
Uncoupling of insulin signalling can occur at numerous points along the pathway and by numerous mechanisms such as decreased expression and/or activity of key signalling components (1) . In particular, insulin receptor substrates (IRS) have been implicated as major targets in insulin resistant states (2) . The IRS family members are defined by a characteristic tandem arrangement of N-terminal pleckstrin homology (PH) and phosphotyrosine binding (PTB) domains. Both these domains are well conserved, particularly between IRS1 and IRS2, and are required for recruitment to and association with the insulin receptor (3, 4) . The remainder of the proteins are poorly conserved across family members but do contain key receptor tyrosine kinase phosphorylation-and Src-homology (SH2) domain binding-sites.
IRS family members play a pivotal role in transmitting insulin signals and are absolutely required for normal insulin-stimulated glucose uptake. Indeed, mice lacking either IRS1 or IRS2 exhibit peripheral insulin resistance and reduced neonatal growth (5) . Despite the similarities between IRS1 and IRS2 some functional differences have also been reported. While IRS2 is crucial for beta cell growth and function, IRS1 is important in regulating metabolism in muscle and adipose tissue (5) . Reductions in IRS1 protein levels and/or active tyrosine phosphorylated IRS1 in these tissues are well documented in models of insulin resistance. Inducers of insulin resistance, such as FFA and TNFα, can also cause posttranslational changes in IRS1, as can activators of serine kinases and/or inhibitors of serine phosphatases (1, 5, 6) . Indeed, serine phosphorylation of IRS1 is currently the bestsubstantiated post-translational modification of IRS proteins, in addition to tyrosine phosphorylation.
Many serine kinases have now been implicated in mediating serine phosphorylation of IRS1 either directly or indirectly. These include Casein Kinase II, PKCα, PKCβΙ/ΙΙ, PKCδ, PKCε, PKCθ, PKCζ, MEK, p38MAPK, JNK1, cRafK, PI3K, AKT/PKB, GSK3β, mTOR, IKKβ, SIK2, AMPK and ROKα (reviewed in (1, 6, 7) ). Most of these kinases appear to negatively regulate insulin signalling, although a few may play a role in positive feedback regulation (8) .
There are however, some serine kinases, such as Casein Kinase II whose role in insulin signalling remains to be defined.
By mapping the specific residues that are targeted by these serine kinases, the mechanistic basis by which serine phosphorylation may uncouple proximal insulin signalling is beginning to be revealed (1) . Recent estimates suggest that IRS1 may contain more than 70 potential serine/threonine phosphorylation sites. However, only 16 have been demonstrated to become phosphorylated in response to agonist stimulation in vivo (9) . Most of these are located proximal to/or downstream of the PTB domain. Phosphorylation of sites that lie close to the PTB domain (e.g. Ser307) can disrupt IR-IRS interactions thereby reducing tyrosine phosphorylation of IRS1 (7, 9, 10) . However, serine phosphorylation in this region can also disrupt IRS-protein tyrosine phosphatase interactions leading to sustained tyrosine phosphorylation of IRS1 (8) . Further downstream, residues such as Ser612, Ser632, Ser662 and Ser570, occur near SH2-binding motifs where they can prevent tyrosine phosphorylation and/or p85 recruitment (11, 12) . Some serine phosphorylation sites have been reported to impinge on intracellular trafficking of IR and/or signalling complex formation (13, 14) .
Finally, serine phosphorylation may also play a role in recruiting chaperones such as 14-3-3 that target IRS1 molecules for proteosomal degradation thereby reducing IR-IRS signalling (15) (16) (17) (18) .
Many of these mechanisms (especially those involving AKT, aPKC, MAPK) are potentially targeted by insulin signalling itself and may represent physiologically relevant pathways involved in negative feedback. It is postulated that the perturbations induced during pathological states such as insulin resistance involve inappropriate activation of these inhibitory pathways. However, additional mechanisms may also exist that are not targeted by insulin but solely by agents that induce insulin resistance. Given the number of potential phosphoserine sites it is also likely that multiple mechanisms are present by which serine phosphorylation of IRS1 can regulate insulin signalling. In this study, we report on the identification of a serine phosphorylation site located in the PH domain of IRS1. This site has recently been identified in an independent study and implicated as a target for IRAK (19) .
Here we show that Ser24 is located in a substrate motif commonly targeted by conventional PKC family of serine kinases and is indeed directly phosphorylated by PKCα in vitro and in vivo. Unlike other serine phosphorylation sites that are linked to PKC activity, Ser24 is not phosphorylated following chronic insulin stimulation and exhibits a pharmacological profile that is distinct from that of Ser307 and Ser612. We also demonstrate that the phosphorylation status of Ser24 plays an important role in regulating lipid binding and intracellular localisation of the IRS1-PH domain. Ultimately this can also impair insulin-stimulated glucose uptake. Hence, serine phosphorylation of the IRS1 PH domain may represent a novel regulatory mechanism that could be important in insulin resistance.
RESULTS

Identification of a putative phosphorylation site in the PH domain of IRS1.
The average occurrence of tyrosine, serine and threonine residues in proteins is estimated to be about, 3%, 7% and 6% respectively (20) . However, in IRS1 almost 15% of the amino acids present are serines, while tyrosines and threonines represent 3% and 5%. This is consistent with the major role of serine phosphorylation in regulating IRS1 function. To identify which residues could represent putative phosphorylation sites in IRS1, we analysed protein sequences with two web-based bioinformatics tools: NetPhos 2.0 and Motif Scan.
NetPhos allowed both sequence and structure-based prediction of protein phosphorylation sites while Motif Scan predicted protein motifs that confer kinase specific substrate sites.
Screening for potential phosphorylation sites using NetPhos 2.0, revealed that all IRS molecules have many more putative serine phosphorylation sites than previously estimated; 113 in hIRS1 (109 in rIRS1). This was substantially greater than the putative phosphothreonine (13 in hIRS1; 15 in rIRS1) and phospho-tyrosine (20 in hIRS1; 21 in rIRS1) sites.
However, the number of putative serine phosphorylation sites represents 62% (for hIRS1) of all serine residues present, a proportion that was similar for the putative phospho-tyrosines (63% for hIRS1). In contrast, only 22% of all threonines in hIRS1 scored highly as putative phosphorylation sites. These comparative estimates appear largely conserved across the six species of IRS1 tested (data not shown). Using Motif Scan a different proportion of putative phosphoserine and phosphotyrosine sites were predicted; This tool predicted 8 phosphotyrosines, 6 phospho-serines and 1 phospho-threonine (under high stringency screen of hIRS1). However, this tool offered the additional information; predicting specific kinases or family of kinases that may target specific phosphorylation sites located in known substrate motifs.
Despite the limitations of each bioinformatics tool, when used in combination and in conjunction with structural alignment analyses, they prove to be very powerful predictors of both potential phosphorylation sites as well as the kinases that may be involved. Indeed, motif scanning of all IRS1 proteins did highlight one serine residue, Ser24, as a putative PKC substrate site ( Figure 1A ). This residue also scored highly (> 0.5) as a putative phosphorylation site in the NetPhos analysis. Sequence-structure alignment further revealed that Ser24 is highly conserved throughout all species of IRS1. However, it is only present in IRS1 and IRS3 and not in IRS2, IRS4, IRS5 or IRS6 ( Figure 1A) . Chico, the Drosophila homolog for IRS1, also appeared to have a putative PKC phosphorylation site in the same location albeit a threonine. Serine 24 is located within the N-terminal PH domain of IRS1 and analysis of the crystal structure of IRS1 PH domain (db:1qqga), confirmed that it is located in the exposed variable loop 1 (VL1) region of this domain, a key area implicated in phosphoinositide binding and PH domain function ( Figure 1A and B) . Collectively, these data suggest that Ser24 is a candidate phosphorylation site for PKCs and may play a role in regulating PH domain function of IRS1.
Protein Kinase C phosphorylate IRS-1 on Ser24 In vitro
To facilitate investigations of site specific phosphorylation events on serine 24 of IRS1, an antibody was generated against the N-terminally, KLH-conjugated Phospho-peptide: indicating that phosphorylation at this site is kinase selective. To confirm that the anti-pSer24
antibody was specific for this site, in vitro kinase assays were repeated in parallel with an IRS1 PH peptide harbouring a S24A mutation ( Figure 2B ). The anti-pSer24 antibody detected phosphorylation of wild type PH domain but not of the S24A mutant peptide.
To investigate whether PKCs phosphorylated Ser24 in the context of full length IRS1, in vitro kinase assays were repeated on immunoprecipitates of IRS1 wt isolated from NIH/hIR/rIRS1wt cells. Figure 2C illustrates the resulting immunoblots wherein full length IRS1 is also phosphorylated in an ATP-dependent manner on Ser24 by PKCα, δ and ζ but not by Casein kinase II. Again the magnitude of phosphorylation was greatest with PKCα and least with PKCζ. The same membrane was sequentially stripped and re-probed with antibodies to pSer307 and pSer612. This allowed us to investigate the action of the kinases on two additional serine phosphorylation sites in IRS1. Figure 2C shows Conventional PKC mediates PMA-stimulated phosphorylation of Ser24, Ser307 and
Ser612
PMA activates DAG-dependent protein kinase C isoforms while C2 ceramide and chronic insulin treatment activate atypical PKCs (22, 23) . In addition numerous downstream serine kinases are also activated in response to all three stimuli and many of these are implicated in insulin resistance. We sought to determine a) which PKC family member(s) may be responsible for mediating PMA-stimulated Ser24 phosphorylation and b) whether the same kinase was responsible for PMA-stimulated phosphorylation at Ser307 and Ser612. The three families of PKCs are distinguishable by their differential requirement for cofactors.
Both conventional PKC (cPKC: α, β, γ) and novel PKCs (nPKC: δ, ε, η, θ) are diacylgycerol-dependent but can be distinguished by their requirement for calcium. In contrast, atypical PKCs (aPKC: ζ, λ, µ) are calcium and diacylgycerol-independent. We took advantage of these functional differences to characterize the PMA-stimulated phosphorylation of Ser24, Ser307 and Ser612. We reasoned that while BAPTA-AM, a chelator of cytosolic free calcium would inhibit only cPKCs, a DAG antagonist such as calphostin would inhibit both cPKC and nPKCs. PMA-induced phosphorylation of Ser24, Ser307 and Ser612 was sensitive to BAPTA-AM pretreatment ( Figure 4A ). This suggests that calcium dependent PKCs are activated by PMA and are required to induce phosphorylation of IRS-1 at these three serine residues. Consistent with this, we observed that serine phosphorylation induced by PMA was completely prevented by pretreatment with Gö6976, an inhibitor of cPKC α, β and µ and Gö6983, an inhibitor of PKC α and β but not µ ( figure 4A ). In contrast, pretreatment with rottlerin, a selective inhibitor of nPKC δ and θ was ineffective ( Figure 4A and C). Unfortunately, calphostin treatment promoted significant degradation of IRS-1 making it difficult to analyse its impact on PMA stimulated serine phosphorylation ( Figure 4A ). Significant cytotoxicity was also observed using this concentration of calphostin (data not shown).
To confirm the involvement of DAG-sensitive PKCs, cells were pre-treated with PMA for 24
hours, a condition known to down-regulate these enzymes. Figure 4A shows that chronic treatment with PMA alone is sufficient to prevent the PMA-induced phosphorylation of Ser24, Ser307 and Ser612. The selective depletion of endogenous PKCs was confirmed in the same samples ( Figure 4B ). PKCα and δ were significantly decreased while PKCµ and ζ levels were unaltered. Neither, PKCβ and λ were detected in these cells (data not shown).
Taken together, these data suggest that PMA-stimulated phosphorylation at all three serine residues requires active conventional PKCs. Of these, PKCα represents the most likely PKC isoform that is required for PMA-stimulated serine phosphorylation of IRS1 on Ser24, Ser307 and Ser612 in NIH3T3 cells.
PMA-stimulated phosphorylation of Ser24, Ser307 and Ser612 exhibit different pharmacological inhibitor profiles
Having established that all three serine residues can be directly phosphorylated by PKCs in vitro ( Figure 3 ) and by PKCα in vivo (Figure 4 ), we next investigated whether PMAstimulated PKCα activation was acting directly on IRS1 or indirectly by activating other downstream serine kinase cascades. To address this, pharmacological inhibitor profiles were constructed for each of the three serine residues using a range of chemical inhibitors that selectively target kinases previously implicated in IRS1 serine phosphorylation. Figure 5A demonstrates that PMA-stimulated phosphorylation of Ser24 was insensitive to the entire panel of six inhibitors used. This argues against the involvement of MEK, JNK, p38, IKKβ, mTOR, GSK3 and PI3K in Ser24 phosphorylation. In contrast, PMA-stimulated phosphorylation of Ser307 and Ser612 was sensitive to inhibition by all the kinase inhibitors (except SB203580) to varying degrees. Both Ser307 and Ser612 phosphorylation exhibited similar profiles but varied in the magnitude of response to individual kinase inhibition. These data suggest that while Ser307 and Ser612 are likely to be phosphorylated by similar kinases, they may vary in their relative affinities to individual kinases. In contrast, Ser24 is likely to be phosphorylated by a distinct kinase that is insensitive to the entire panel of inhibitors used in this experiment. As PKCα is insensitive to these inhibitors it remains a good candidate for the direct phosphorylation of Ser24 but it is likely to play an indirect role in PMA-stimulated phosphorylation of Ser307 and Ser612 (figure 5B).
PKCα α α α interacts with IRS-1 PH domain.
The direct interaction between full length IRS-1 and PKCα has been reported (24) . To test whether the IRS1-PH domain alone could mediate this interaction, GST-pull down assays were performed using recombinant PKCα incubated with either GST alone or GST fused to IRS1-PH domain. Figure 6 confirms that PKCα can be identified only in GST
immunoprecipitates that contain IRS-1 PH domain. Subsequent in vitro kinase assays confirmed that this kinase-substrate complex contained sufficient levels of PKC to induce detectable phosphorylation on Ser24. These findings are in agreement with other studies suggesting that PKCα can directly interact with IRS1 (24) and that the PH domain is sufficient for this interaction (25) .
Functional role of Serine 24 Phosphorylation
Recombinant IRS-1 PH-PTB domain peptides have been reported to bind phosphoinositides (26) . To confirm that the IRS1-PH domain alone was sufficient to bind phospholipids, the relative affinity of recombinant GST-IRS-PH domain fusion peptide to various phosphoinositides was determined using a time resolved FRET assay (27) . Under these assay conditions, PtdIns(4,5)P 2 was the only phosphoinositide to bind with any appreciable affinity The ability of PH domains to bind PtdIns(4,5)P 2 is often also reflected in their ability to associate with PtdIns(4,5)P 2 rich membranes such as plasma membrane. Indeed, IRS-1 PH domain has been reported to localise to the cell periphery (28, 29) . To determine whether phosphorylation of Ser24 could impact on this function of the IRS-1 PH domain, confocal fluorescent images were taken of HEK293 cells transfected with either GFP alone, GFPtagged IRS-1 PH wt or GFP-tagged IRS-1 PH Ser24 mutant peptides. As illustrated in figure 8 , GFP alone is uniformly distributed throughout the cell cytoplasm and nucleus. However wild type GFP-IRS-1PH domain is found in the nucleus but is also localised to the cell periphery. This is consistent with its ability to bind PtdIns(4,5)P 2 which is particularly abundant in the plasma membrane of these cells. In contrast, the S24D mutant does not exhibit any discernable peripheral localisation while the S24A mutant can be found at the cell periphery ( figure 8 ).
Loss of PH domain function has potential to negatively impact on insulin sensitivity. To 
DISCUSSION
Serine phosphorylation sites in IRS-1
Serine phosphorylation of IRS1 is an important mechanism for attenuating insulin signalling.
IRS1 is also unusually rich in serine residues and recent reports suggest that more than 70 serines appear in consensus phosphorylation sites for kinases (9) . However, given that knowledge of preferred substrate motifs in the entire kinome remains limited, the number of sites that can potentially be phosphorylated is likely to be significantly greater. Indeed, 
Role of Serine 24 phosphorylation in PH domain function
By analogy to the crystal structure of human IRS1 PH-PTB peptide, Ser24 of rIRS1 lies in a large exposed cationic patch that is present at the base of the PH domain. This region includes the putative phosphoinositide interacting residues Lys 21, Lys 23 His 26 and Arg 28, Lys 61 and Arg 62 (highlighted in figure 1B ) (26) . Substitution of at least one of these, R28C
is sufficient to disrupt lipid binding to PH domain (30) as well as PHIP interaction (31) . Our findings suggest that the addition of a charged phosphate group on Ser24 can also induce significant changes to cationic patch and alter lipid interactions ( Figure 7B-C) . This modification is also sufficient to alter both intracellular localisation ( Figure 8 ) and subsequent participation in insulin-stimulated glucose uptake ( Figure 9C ). These observations are entirely consistent with a recent independent study demonstrating that IRS1-S24D mutant shows impaired insulin-stimulated IR-IRS-1 interactions, tyrosine phosphorylation of IRS-1, recruitment/activation of PI 3-Kinase and insulin stimulated Glut4 translocation (19) .
A surprising observation in our studies was that an alanine substitution of Serine 24 did not behave in a fashion akin to a non-phosphorylated peptide (figures 7B, 8 and 9C). Indeed, this mutation consistently produced actions that were intermediate between wild type and the pseudophosphorylated Ser24. One possible explanation for these observations is that serine 24 is also involved in hydrogen bonding to a main-chain amide ( (26) and Figure 1 ) and substitution with an alanine is sufficient to disrupt this bond and hence alter the functionality of the PH domain. It is intriguing to speculate that in addition to altering the electrostatic properties of the cationic patch, phosphorylation of Ser24 may also significantly alter PH domain structure by disrupting this hydrogen bond.
The PH domains of IRS1 and IRS2 are more similar to each other (58% identical and 78% similar) than to IRS3 (IRS1-PH is 37% identical and 63% similar to IRS3 and IRS2-PH is 33% identical and 57% similar to IRS3) (32) . Hence, it is surprising that Ser24 is not conserved amongst IRS1 and IRS2, rather that it is present in IRS3 and IRS_CHICO. It is interesting to note that functional differences between the PH domains of IRS1 and IRS2
have been reported (33, 34) . Whether this is accomplished by differential regulation of PH domains by Ser24 phosphorylation remains a possibility.
Recently, two other proteins have been reported to be phosphorylated in their PH domains following PKC activation (30, 31) . As with IRS1-Ser24, these phosphorylation events are also sufficient to disrupt phosphoinositide binding (35) and membrane translocation (36) .
Intriguingly, DGKδ1-PH is also phosphorylated by cPKCs and the targeted serine site is also located in an analogous region. Both these serine sites are predicted as putative PKC phosphorylation sites in our bioinformatics analysis (data not shown). This further validates the use of bioinformatic software in hypothesis generation.
Role of PKCα α α α in Ser24 phosphorylation
In this study, we show that in vitro, IRS1-Ser24 is a substrate for representatives of all three PKC subfamilies (α, β and ζ). However, this relative lack of specificity is not recapitulated in vivo. In intact NIH/IR/IRS1 cells, agonist-induced phosphorylation of Ser24 was selective for specific PKC isoforms. Ser24 is phosphorylated following activation of phorbol esterdependent kinases and not by C2-ceramide or chronic insulin treatment. This suggests an involvement of DAG dependent PKCs. PMA-stimulated phosphorylation of Ser24 is likely to be mediated by conventional PKCα, as it is sensitive to inhibition by the calcium chelator, BAPTA-AM, inhibitors of cPKC (i.e. Gö6976 and Gö6983), chronic PMA treatment and neither PKC β nor γ are present in NIH3T3 cells (22) . This conclusion is also consistent with the in vitro observations wherein PKCα consistently produced the most robust phosphorylation at this site. It is therefore likely that PKCα is a preferred kinase to phosphorylate Ser24.
It is interesting to note that Motif scan predicted Ser24 to be preferred by PKCζ as a substrate site. Also the amino acid sequence flanking Ser24 does not conform to two commonly cited consensus sequences for substrates of classic/generic PKCs i.e., X-S/T-X-R/K (Prosite pattern and (37)) or R-X-X-S/T (9). However, it is in absolute agreement with PKC isoform specific sequence motifs reported by Cantley and colleagues (38) . They report that all PKCs prefer substrates that have basic residues is -3 position and a hydrophobic amino acid must occupy position +1. Additionally, cPKCs prefer substrates with basic residues particularly at positions +2 and +3, while nPKC and aPKC tend to prefer hydrophobic residues at these positions. In IRS1 Ser24 is flanked by such residues in the positions that confer this as a preferred phosphorylation site for cPKCs. Therefore our experimental evidence is entirely consistent with this particular motif-based prediction 1 . This consensus motif together with our in vivo and in vitro data suggests that PKCα is likely to directly phosphorylate Ser24.
The finding that PMA-stimulated Ser24 phosphorylation is not affected by any of the non-PKC inhibitors ( Figure 5 ) further supports this notion, as does the findings that IRS1 and PKCα are constitutively associated in vivo (39, 40) and that the PH domain itself is sufficient for this interaction ( Figure 6 ).
One possibility that cannot be excluded is that differences in endogenous levels, relative activities and/or intracellular location of different PKC isoforms may also determine Ser24 phosphorylation in vivo. In this regard, PKC α, δ µ and ζ are all expressed in NIH3T3 fibroblasts ( Figure 4B ) but only PKCα is involved in PMA-stimulated Ser24 phosphorylation. Whether this also occurs in other cell types that express cPKC β and/or γ isoforms warrants further investigation.
Role of PKCα α α α in insulin resistance
Attempts to address the role of cPKCs in insulin signalling have produced conflicting data.
Studies using PKC inhibitors and phorbol ester-induced PKC down regulation have suggested that diacylglycerol (DAG)-activated PKCs are not required for normal insulinstimulated glucose uptake in adipocyte and muscle cells. In contrast, the targeted disruption of murine PKCα does enhance insulin signalling through IRS1 leading to increased insulinstimulated glucose transport in adipocytes and skeletal muscle (41) . It is therefore possible that PKCα may serve as a tonic endogenous inhibitor of IRS1 dependent pathways (23) .
While the role of cPKCs in physiological responses to insulin remain unresolved, it is clear that over expression or activation of DAG dependent PKCs can significantly impair insulin signalling (42, 43) . Indeed, elevated PKCα, δ and θ activities are implicated in insulin resistance in vivo (44, 45) . Our observation that IRS1 Ser24 is not phosphorylated in response to insulin but only following PMA stimulation suggests that this site may represent a novel diagnostic marker of elevated cPKC activity that may occur in pathophysiological states such as insulin resistance and hyperglycemia (23) .
pSer24 exhibits characteristics that are distinct from pSer307 & pSer612
As with Ser24, we found that PKCs could directly phosphorylate Ser307 and Ser612, in vitro but PMA-stimulated phosphorylation required active PKCα, in vivo. This could suggest that these sites are also the direct targets of cPKC activity. However, neither site lies within a consensus motif for PKC substrates and unlike PMA-stimulated pSer24, both pSer307 (312 in hIRS1) and pSer612 (616 in hIRS1) were sensitive to other serine kinase inhibitors. This implicates other downstream serine kinases in the direct interaction and phosphorylation of Ser307 and Ser612. Indeed Ser612 was identified as a target for active PKCs and Erk (46) while Ser307 is targeted by numerous kinases including JNK, IKKβ, ΑΚΤ and mTOR (47) (48) (49) . Figure 5B summarises the residue selective roles of PMA-responsive serine kinases in IRS1 phosphorylation. Future studies should help delineate the specific serine kinase and upstream kinase pathways that directly target these sites.
An additional novel observation made during our studies was that although casein kinase II has little effect on Ser24 phosphorylation, it does directly phosphorylate Ser307 and Ser612
in vitro. This activity on full length IRS1 was also sufficient to cause the most significant can significantly alter PH domain function and impair insulin sensitivity. Future studies will address whether phosphoSer24 has potential for use diagnostic marker for detection of pathological signalling events that occur during insulin resistance and hyperglycemia.
MATERIALS & METHODS
Materials
Recombinant PKC isoforms were purchased from Calbiochem. The specific primary antibodies used were anti-myc (9E10-T Siddle Lab, or 4A6 Upstate), anti-pSer307-rIRS1
(Upstate #07-247), anti-pSer616-hIRS1 (equivalent to pSer612 in rIRS1; Biosource Ltd. #44- 
Bioinformatic analysis
Protein sequences for IRS family members were systematically analysed with two computational tools that predict putative phosphorylation sites. NetPhos 2.0 (www.cbs.dtu.dk/services/NetPhos/) based on neural network predictions for serine, threonine and tyrosine phosphorylation sites (50) 
Generation of Anti-pSer24 IRS1 Antibody
The generation of Anti-pSer24-IRS1 was commissioned from Cambridge Research Biochemicals Ltd. UK. Briefly, rabbit anti-sera were generated against the following N- 
In vitro lipid binding assay
Lipid binding was determined using a Time Resolved FRET assay as described (27) 
Cell culture
BOSC23 cells and 3T3-L1 preadipocytes were routinely propagated in DMEM containing 4.5 g/L glucose, 10 % bovine calf serum (Hyclone), 50 U/ml penicillin, and 50 µg/ml streptomycin at 10% CO2. HEK293 were propagated in DMEM containing 4.5 g/L glucose, 10 % new born calf serum, 50 U/ml penicillin, 50 µg/ml streptomycin at 5% CO2. NIH/hIR cells, mouse fibroblasts overexpressing the human insulin receptor (and G418 resistant) were grown in the same medium as HEK293 cells but with the addition of 600 µg/ml G418.
Generation of stable cell lines expressing rIRS1 mutants
3T3-L1 and NIH/hIR cells stably expressing myc-his tagged IRS1 were generated by retroviral mediated gene transfer (55). Briefly, sub confluent BOSC23 packaging cells were transfected with pBabePuro-rIRS1mychis plasmids and conditioned media was collected 48hrs later. This was passed through a 0.45 µm filter, supplemented with 16 µg/ml of polybrene and used to infect proliferating 3T3-L1 preadipocytes or NIH/hIR cells. Drug selection with puromycin (4µg/ml for 3T3-L1 and 16 µg/ml for NIH/hIR) was initiated two days later. After a week in drug selection, stable cell lines were confirmed by western blot analysis and expanded. Stocks were frozen in liquid nitrogen until required.
Adipocyte differentiation and Glucose uptake
Two days post confluent 3T3-L1 preadipocytes expressing either empty vector or full length IRS1 mutants were maintained at 10% CO2 in adipocyte media (AM: high glucose DMEM containing antibiotics, 10% Cosmic Calf Serum ® Hyclone , 4µg//ml puromycin). Adipocyte differentiation was induced by incubated for two days in AM supplemented with induction cocktail (5mg/ml Insulin, 0.5mM IBMX and 1µM Dexamethasone). This was followed by a further two day incubation in AM supplemented with insulin only. Thereafter cells were fed unsupplemented AM every two days. Glucose uptake assays were performed on fully differentiated adipocytes using 2-deoxy-D-[2,6 3 H]-glucose uptake as previously described (56) .
Confocal Fluorescence Microscopy
HEK293 cells were grown on poly-L-lysine coated coverslips and transiently transfected with either pNEGFP, pNEGFP-IRS1-PH wt, pNEGFP-IRS1-PH S24A, pNEGFP-IRS1-PH S24D.
Twenty-four to 48hours post-transfection, monolayers were serum starved (over night),
washed with PBS, fixed in 2% Formalin and mounted in DAPI containing Vectorshield® mount medium (Vector labs Inc.). Confocal Fluorescence Microscopy was performed using a Zeiss laser confocal microscope system (LSM510) and a 60X oil emersion objective.
Fluorescent images were captured using Argon 488nm (GFP) and Krypton 413nm (DAPI) lasers and a confocal slice thickness of <0.8µm.
Phospho-protein extraction and analysis
Two day post-confluent cells were washed and incubated with serum free medium and GST-IRS1-PH domain. In vitro kinase assays were performed on GST precipitates followed by SDS-PAGE and immunoblotting against pser24, active PKCα, GST, and PKCα. washed with PBS, fixed in 2% Formalin and mounted in aqueous mount. Confocal fluorescent images were captured using a Zeiss imaging microscope set to capture GFP and DAPI blue flouresence from a slice thickness of 0.8nm using a 60X oil emersion objective.
Representative pictures are shown from at least three independent experiments performed in duplicate. 
